All stock lists
Essex Property Trust, Inc. (New York Stock Exchange:ESS)
US · Delayed Price · Currency is USD
Also listed: 0IIR.LReal Estate · REIT - Residential
$271.80-$2.20 (-0.80%)
Market cap
$17.5B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 7, 1994
Website
Insider Score
––Not scored
ESS Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
ESS analyst forecast
ESS analyst consensus
Hold13 ratings
Buy 5 Hold 7 Sell 1
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
ESS 12-month price target
$296.27+9.0% upsideaverage of 11 firms
$326.00High
$273.00Low
Best analysts covering ESS
- JP Morgan100%success rate · +7.5% avg return · 1 call
- Piper Sandler67%success rate · +6.7% avg return · 9 calls
- Scotiabank58%success rate · +4.8% avg return · 12 calls
- Raymond James50%success rate · +4.5% avg return · 4 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ESS analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-11-11 |
| UBS | Neutral | $286.00 | +3.7% | Reiterated | 2026-11-10 | |
| Truist Securities | Hold | $273.00 | +7.2% | Reiterated | 2026-11-10 | |
| Cantor Fitzgerald | Overweight | $316.00 | +9.7% | Reiterated | 2026-11-09 | |
| RBC Capital | Outperform | $288.00 | +9.7% | Reiterated | 2026-10-29 | |
| Piper Sandler | Overweight | $326.00 | +20.0% | Reiterated | 2026-10-29 | |
| — | Stifel | Hold | — | — | Reiterated | 2026-10-28 |
| Wells Fargo | Equal Weight | $297.00 | +1.0% | Reiterated | 2026-10-19 | |
| Barclays | Equal Weight | $296.00 | -0.5% | Reiterated | 2026-10-14 | |
| Evercore ISI Group | Outperform | $295.00 | +8.2% | Reiterated | 2026-09-21 | |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2026-09-17 |
| — | Mizuho | Neutral | — | — | Downgraded | 2026-09-08 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2026-08-14 |
| — | Citizens | Market Outperform | — | — | Upgraded | 2026-07-31 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-07-21 |
| Raymond James | Outperform | $320.00 | +12.1% | Upgraded | 2026-06-26 | |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-06-10 |
| Wells Fargo | Equal Weight | $280.00 | +9.4% | Reiterated | 2026-06-01 | |
| Evercore ISI Group | Outperform | $295.00 | +8.2% | Upgraded | 2026-06-01 | |
| UBS | Neutral | $278.00 | +3.0% | Reiterated | 2026-05-14 | |
| Scotiabank | Sector Outperform | $320.00 | +12.5% | Reiterated | 2026-05-14 | |
| Barclays | Equal Weight | $272.00 | +6.5% | Reiterated | 2026-05-11 | |
| — | Piper Sandler | Overweight | — | — | Upgraded | 2026-05-04 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-05-04 |
| Evercore ISI Group | In Line | $271.00 | +9.4% | Reiterated | 2026-04-06 | |
| Barclays | Equal Weight | $290.00 | +11.4% | Reiterated | 2026-03-06 | |
| — | Baird | Neutral | — | — | Reiterated | 2026-03-02 |
| — | Raymond James | Market Perform | — | — | Downgraded | 2026-02-27 |
| BMO Capital | Market Perform | $280.00 | +9.0% | Downgraded | 2026-01-09 | |
| UBS | Neutral | $274.00 | +9.1% | Reiterated | 2026-01-08 | |
| Jefferies | Hold | $282.00 | +8.7% | Downgraded | 2025-12-16 |
ESS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-04 | $1.45 | $1.25 | $474.0M | $477.3M |
| 2026-04-28 | $1.42 | $1.65 | $479.9M | $482.4M |
| 2026-07-29 | $1.46 | $0.97 | $485.1M | $486.7M |
| 2026-10-27 | $1.47 | $1.52 | $491.0M | $492.7M |
| 2027-02-03Upcoming | $1.49 | — | $494.1M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.